Santen and Aerie Pharmaceuticals have announced an exclusive development and commercialization partnership for Rhopressa/Rhokiinsa (netarsudil ophthalmic solution) 0.02% and Rocklatan/Roclanda (netarsudil and latanoprost ophthalmic solution) 0.02%/0.005%.
Envision will help students who are blind or visually impaired to enter college and workforce with the acquisition of the College Success Program (CSP).
Erin Parsons has been appointed to Alimera Sciences' Board of Directors. Ms. Parsons has more than 20 years of experience in the ophthalmology sector.
LayerBio announced that the United States Patent and Trademark Office (USPTO) has issued US Patent No. 11,185,441 for its OcuRing Drug Delivery Platform.
Visus Therapeutics has revealed positive topline results from VIVID, the company’s Phase 2 study of three novel topical ophthalmic formulations under investigation for the treatment of presbyopia.
The Notal Vision Monitoring Center is celebrating the ten millionth test completed by over 20,000 patients using the FDA-cleared ForeseeHome gadget, which was analyzed through artificial intelligence (AI).
Kubota Vision announced the publication of a new paper in the journal Scientific Reports: “Effect of short-term peripheral myopic defocus on ocular biometrics using Fresnel “press-on” lenses in humans”.
Inspired by the Golden Ratio, VSY Biotechnology GmbH with its trifocal technology has created an intraocular lens that has virtually the same conditions as the natural refraction of light waves in the human eye.
Dutch Evmann Investments Holding BV, which produces and sells high-quality, innovative products in the field of Ophthalmology and Orthopedics is searching for a substantial investment opportunity in the United States.
Hilco Vision announced the acquisition of Belgium and Netherlands-based Simovision BV as of November 17, 2021.